Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.8 USD | +0.41% | -2.05% | +11.46% |
Financials (USD)
Sales 2024 * | 431M | Sales 2025 * | 653M | Capitalization | 6.44B |
---|---|---|---|---|---|
Net income 2024 * | -152M | Net income 2025 * | -104M | EV / Sales 2024 * | 13.8 x |
Net cash position 2024 * | 514M | Net cash position 2025 * | 444M | EV / Sales 2025 * | 9.18 x |
P/E ratio 2024 * |
-46.3
x | P/E ratio 2025 * |
-63
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.97% | Free-Float | 99.1% |
Latest transcript on Blueprint Medicines Corporation
1 day | +0.41% | ||
1 week | -2.05% | ||
Current month | +12.56% | ||
1 month | +11.44% | ||
3 months | +14.88% | ||
6 months | +50.20% | ||
Current year | +11.46% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 102.8 | +0.41% | 401,436 |
24-05-23 | 102.4 | -0.31% | 551,246 |
24-05-22 | 102.7 | -0.89% | 385,996 |
24-05-21 | 103.6 | -0.60% | 423,398 |
24-05-20 | 104.3 | -0.67% | 468,869 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.46% | 6.44B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- BPMC Stock